Australia's largest stock trading and investment forum Australia's #1 stock forum

BLT

Click for more information

0.00%

2.6¢ benitec biopharma limited

All this may be true, but we have seen just much “success” with...

First 8 Last

Share
Profile

Follow
Blane66

2,524 Posts.

69

25/11/18

13:52

Post #: 36632114
Share

Originally posted by lawrence1967: ↑

I think the document reaffirms that Axovant and Benitec have seen great potential in the use of ddrnai to treat neuromuscular and neurological conditions and want to maintain a competitive advantage. Also, Axovant must have seen very compelling data on OPMD and sheep trials to give Benitec 10 million cash, five additional fully-funded programs and commitments to pay nearly 200 million in milestones - around 20 million due early next year. Think about it. Axovant had its own trial failure which would make them highly motivated to do their due diligence with their new gene therapy programs.

Expand

All this may be true, but we have seen just much “success” with benitec’s tech as they have. Only time and clinical trials will tell.

BLT Price at posting: 14.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

There are more pages in this discussion • 2 more messages in this thread...

First 8 Last

Add BLT (ASX) to my watchlist